Evidence map›Paper›PMID 28893907›Full record

ArticleThe Journal of biological chemistry2017

Compositional and expression analyses of the glideosome during the

Judith L Green, Richard J Wall, Juha Vahokoski, Noor A Yusuf, Mohd A Mohd Ridzuan, Rebecca R Stanway, Jessica Stock, Ellen Knuepfer, Declan Brady, Stephen R Martin and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DissectingACS omega · 2022
    Article
  13. Article
  14. Article
  15. Full-lengtheLife · 2020
    Article
  16. Article
  17. Peptide Probes forACS chemical biology · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 7 countries.

Judith L GreenFrom the Malaria Parasitology Laboratory, judith.green@crick.ac.uk.
Richard J Wallthe School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
Juha Vahokoskithe Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Noor A YusufFrom the Malaria Parasitology Laboratory.
Mohd A Mohd RidzuanFrom the Malaria Parasitology Laboratory.
Rebecca R Stanwaythe Institute of Cell Biology, University of Bern, Bern, Switzerland, and.
Jessica Stockthe School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
Ellen KnuepferFrom the Malaria Parasitology Laboratory.
Declan Bradythe School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
Stephen R MartinStructural Biology and.
Steven A HowellMass Spectrometry Science Technology Platforms, and.
Isa P Piresthe Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7, 90220 Oulu, Finland.
Robert W MoonFrom the Malaria Parasitology Laboratory.
Justin E MolloySingle Molecule Enzymology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom.
Inari Kursulathe Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Rita Tewarithe School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
Anthony A HolderFrom the Malaria Parasitology Laboratory, tony.holder@crick.ac.uk.ORCID 0000-0002-8490-6058
Institute of Parasitology · CZUniversity of Nottingham · GBMalaria Consortium · GBUniversity of Bergen · NOIONICS Mass Spectrometry (Canada) · CAThe Francis Crick Institute · GBUniversity of Bern · CHUniversity of Oulu · FI

Funding

Medical Research Council G0900109Medical Research Council G0900278Medical Research Council MR/K011782/1Medical Research Council MR/N023048/1Wellcome Trust
6 · The paper itself

Abstract

Myosin A (MyoA) is a Class XIV myosin implicated in gliding motility and host cell and tissue invasion by malaria parasites. MyoA is part of a membrane-associated protein complex called the glideosome, which is essential for parasite motility and includes the MyoA light chain myosin tail domain-interacting protein (MTIP) and several glideosome-associated proteins (GAPs). However, most studies of MyoA have focused on single stages of the parasite life cycle. We examined MyoA expression throughout the

Indexed as

Membrane ProteinsMyosinsPlasmodium bergheiPlasmodium falciparumProtozoan ProteinsAnimalsHumansLife Cycle StagesMiceMembrane ProteinsMyoA protein, Plasmodium bergheiMyosinsProtozoan Proteinscell motilityglideosomeinvasionmalariamyosinmyosin light chainplasmodium

Identifiers

PMID28893907
PMCPMC5663884
OpenAlexW2756164895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.